In a major win for Sarepta Therapeutics Inc., US regulators are recommending that patients who can walk be allowed to take its gene therapy Elevidys again.The Food and Drug Administration’s sudden ...

Revenue at SoFi jumps 44%, UnitedHealth restores financial guidance, and Sarepta soars after being notified by the FDA the company may lift its voluntary pause on shipments of Elevidys for ambulatory ...